Astrana Health, Inc. (ASTH)

Market Cap	1.12B
Revenue (ttm)	2.90B +68.2%
Net Income	9.54M -84.7%
EPS	0.20 -85.0%
Shares Out	50.16M
PE Ratio	114.71
Forward PE	24.28
Dividend	n/a
Ex-Dividend Date	n/a

Volume	500,225
Open	22.00
Previous Close	22.00
Day's Range	22.00 - 22.85
52-Week Range	20.12 - 39.97
Beta	0.87
Analysts	Strong Buy
Price Target	41.33 (+84.43%)
Earnings Date	Mar 2, 2026

About ASTH

Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients pr...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1994
• Employees: 1,900
• Stock Exchange: NASDAQ
• Ticker Symbol: ASTH
• Website: https://www.astranahealth.com

Financial Performance

In 2024, Astrana Health's revenue was $2.03 billion, an increase of 46.72% compared to the previous year's $1.39 billion. Earnings were $43.15 million, a decrease of -28.93%.

Analyst Summary

According to 9 analysts, the average rating for ASTH stock is "Strong Buy." The 12-month stock price target is $41.33, which is an increase of 84.43% from the latest price.

Price Target

$41.33

(84.43% upside)

Analyst Consensus: Strong Buy